NCT00195195已完成不适用
A Rapamune Follow-up Registry in Transplant Recipients in the Nordic Countries, "Wrap-up"
Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 66 人开始时间: 2005年1月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 66
研究概览
简要总结
The purpose of this study is to gather information about the long-term effects and safety of treatment with Rapamune in transplant patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Transplantation patients treated with sirolimus (Rapamune).
排除标准
- •Patients must be able to give informed consent.
研究组 & 干预措施
1
Sirolimus
干预措施: Sirolimus (Drug)
研究者
相似试验
进行中（未招募）
不适用
Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of KidneysKidney Transplantation in Highly Sensitized PatientsNCT05714514Hansa Biopharma AB64
已完成
不适用
Heart Transplant Registry of VárosmajorDisorder Related to Cardiac TransplantationNCT02347371Semmelweis University Heart and Vascular Center11
招募中
不适用
Long-Term Follow-Up of Recipient of Gene Transfer ResearchRetroviridae InfectionsCancerNCT01492036M.D. Anderson Cancer Center130
已完成
不适用
Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In HypercholesterolaemiaHypercholesterolaemiaNCT01352897AstraZeneca800
已完成
不适用
Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein OcclusionMacular OedemaRetinal Vein OcclusionNCT01566526Allergan26